SBIR/STTR Research Award
NOVEL APPROACH TO TIPS: STENT POLYMER PAVING COMPOSITES
Award amount
$92,775Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BERKLEY APPLIED SCIENCE & ENGR, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Verbatim From Applicant's Abstract): In the management of
cirrhotic patients with variceal bleeding, transjugular intra-hepatic
portosystemic shunt (TIPS) plays an important role in decompressing the portal
system and preventing the danger of frequent rebleeding. The advance of this
less invasive, non-surgical approach of portal decompression was made possible
through the clinical introduction of vascular stents. At first, balloon
expandable stents, such as Palmaz stents or Tantalum Strecker stents were
employed in TIPS procedure, however, in time, many switched to self-expanding
stents such as Wallstent, Nitinol Stecker stents, Memotherm stents, or
GianturcolRosch stents, which became more popular due to their easier
deployment and variety of size available. However, there are intrinsic
differences among all self-expanding stents regarding elasticity, length,
diameter, longitudinal flexibility hoop strength, mesh profile, and delivery
system, which influence their performance.
Despite the clinical success of TIPS to date, several major challenges remain.
Early malfunction of TIPS may occur due to tract closure resulting from
bioleakage intralumina! thrombosis, incomplete stent expansion, or stent
migration. More commonly, TIPS patency is compromised progressively in the
months following placement due to tissue in-growth. These and other limitations
of current TIPS practice must be resolved to ensure durable patency and
efficacy rates for TIPS. It is the specific objective of this Phase I project
to resolve some of these limitations through introduction of a composite
nitinol stent combined with in adherent polymeric endoluminal layer. Berkeley
Applied Science & Engineering, Inc. (BASE) has developed a unique expertise in
using nitinol for various industrial and medical applications. The
co-investigator, Dr. Slepian, was the original inventor and developer of
polymeric endoluminal paving. During Phase l.a combination of strengths will be
utilized, including mathematical simulation of BASE and the polymeric expertise
of the Slepian lab. Prototype stent samples will be fabricated and a limited
animal study will be done to demonstrate how present limitations of TIPS
procedure can be improved.
PROPOSED COMMERCIAL APPLICATION:
Not Available
Technology keywords
Not reported